Altamira Therapeutics Ltd. (CYTO) Financials

The income statement of Altamira Therapeutics Ltd. (CYTO) provides a comprehensive overview of the company's financial performance. It highlights the revenue generated by the company during a specified period and showcases the various expenses incurred in running the business. This financial statement is crucial for investors and stakeholders as it helps them evaluate the profitability and efficiency of the company. The income statement also includes the gross profit, which is the difference between the revenue and the cost of goods sold. It gives insight into the company's ability to generate profits.

EBIT, or Earnings Before Interest and Taxes, is a key measure used to assess Altamira Therapeutics Ltd.'s profitability. It represents the company's operating income before deducting interest expenses and income taxes. EBITDA, or Earnings Before Interest, Taxes, Depreciation, and Amortization, is another important metric used by investors to evaluate the company's financial performance. It provides a more accurate picture of the company's operational profitability by excluding non-cash expenses like depreciation and amortization from the equation.